Connection
David Lynch to Triterpenes
This is a "connection" page, showing publications David Lynch has written about Triterpenes.
|
|
Connection Strength |
|
|
|
|
|
0.898 |
|
|
|
-
Profeta V, McIntyre K, Wells M, Park C, Lynch DR. Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia. Expert Opin Investig Drugs. 2023 Jan; 32(1):5-16.
Score: 0.898